Medicinal product name Betmiga
Pharmaceutical form Prolonged-release tablet
Strength 50 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/12/809/010N30 Is available
Legal status Rx Prescription (Pr.)
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code G04BD12 Urologicals

Important notice

Additional information regarding the use for persons aged 75+

If used as "UROLOGICALS"
SubstanceClassComment
MirabegronumBLack of research evidence, clinical experience or efficacy among older persons. Elimination is reduced in renal insufficiency. Take interactions into account.

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(54 containers)
Tamro, Magnum Medical, Recipe Plus N30
(50 mg)
Al/Al blister 57.92  EU/1/12/809/010  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/12/809/010
Date of authorisation Dec 20, 2012
MA valid until For unlimited time
Marketing authorisation holder, country Astellas Pharma Europe B.V., Netherlands